ADMA - ADMA Biologics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue10,661.0377,177.6335,915.545
Cost of Revenue6,360.7614,311.4613,742.367
Gross Profit4,300.2762,866.1722,173.178
Operating Expenses
Research Development7,688.2387,015.9469,517.014
Selling General and Administrative13,942.43311,364.0338,674.697
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-17,330.395-15,513.807-16,018.533
Income from Continuing Operations
Total Other Income/Expenses Net54.813-613.407-60.139
Earnings Before Interest and Taxes-17,275.582-16,127.214-16,078.672
Interest Expense2,239.5691,842.7161,286.215
Income Before Tax-19,515.151-17,969.93-17,364.887
Income Tax Expense---551.724
Minority Interest---
Net Income From Continuing Ops-19,515.151-17,969.93-16,813.163
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-19,515.151-17,969.93-16,813.163
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-19,515.151-17,969.93-16,813.163